Clinical Study
Resveratrol Promotes Foot Ulcer Size Reduction in Type 2 Diabetes Patients
Table 3
Multiple linear regression models for ulcer size reduction.
| Models | Coefficients (SE) | [1] | [2] | [3] |
| Resveratrol | −1.382* (0.567) | −1.322* (0.562) | −1.338* (0.489) | Baseline ulcer size | 0.717*** (0.0917) | 0.783*** (0.0691) | 0.824** (0.0688) | Baseline insulin | | −0.0635 (0.0356) | −0.0506 (0.0319) | Ulcer duration, months | | 0.0103 (0.0185) | | Baseline Wagner | | 0.609 (0.660) | | Baseline CRP | | −0.247** (0.0864) | −0.222*** (0.0582) | _cons | −0.293 (0.602) | −0.251 (1.157) | 0.351 (0.625) |
| | 24 | 24 | 24 | | 0.835 | 0.900 | 0.895 | adj. | 0.819 | 0.865 | 0.873 | rmse | 1.348 | 1.163 | 1.128 |
|
|
Standard errors in parentheses. , , and .
|